MADELINE V HOGLUND
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BOULDER, CO NPI 1962802488
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CO REVANCE THERAPEUTICS, INC. All categories
General Payments — all program years on this page
$699.16
- Category: General Payments
- Program years: PY2021–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $264.15 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $264.15 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $178.84 | 6 |
| Galderma Laboratories, L.P. | $85.31 | 2 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1145364679 | Galderma Laboratories, L.P. | $49.73 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145364681 | Galderma Laboratories, L.P. | $35.58 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147942239 | REVANCE THERAPEUTICS, INC. | $77.38 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147942241 | REVANCE THERAPEUTICS, INC. | $6.14 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147942243 | REVANCE THERAPEUTICS, INC. | $22.47 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147942245 | REVANCE THERAPEUTICS, INC. | $10.34 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147942247 | REVANCE THERAPEUTICS, INC. | $8.81 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147942249 | REVANCE THERAPEUTICS, INC. | $53.70 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.